AI Maps 766 Genes Linked to Schizophrenia, Expanding Genetic Understanding

Researchers have utilized AI-based computational models to identify 766 genes associated with schizophrenia, significantly expanding the known genetic map of the disorder. The study, published in Nature Genetics, suggests that the condition emerges from an interconnected network of genetic variants rather than isolated mutations.

To achieve these results, a collaborative team involving the University of Bari and the Lieber Institute for Brain Development analyzed genetic data from more than 102,000 individuals. The team further refined their findings by examining brain tissue samples across six different brain regions. Of the 766 genes identified, 641 had not been previously detected in transcriptomic analyses, marking a substantial leap in the volume of known genetic associations.

The Polygenic Nature of Schizophrenia

Schizophrenia is a complex psychiatric disorder characterized by cognitive impairments, delusions, and hallucinations. Unlike disorders caused by a single gene, schizophrenia is polygenic, meaning it results from the cumulative impact of hundreds of genetic variants that affect how neurons communicate and develop.

Historically, researchers could only identify a small fraction of these variants. Describing the breakthrough, researchers told Wired that the discovery is akin to turning on the lights in an entire neighborhood; where they previously could only see a few lit houses, they can now visualize a much larger portion of the disease's genetic architecture.

Implications for Treatment

This shift in perspective—from viewing the disease as a collection of isolated mutations to seeing it as a coordinated biological network—allows scientists to investigate the behavior of the disorder with greater precision. By mapping this detailed architecture, the research provides a necessary foundation for developing more targeted therapeutic interventions. Understanding these complex biological interactions is critical to deciphering how a diverse array of symptoms emerges in different patients.

Global Impact and Next Steps

The scale of this research is particularly urgent given the global prevalence of the disorder. According to the World Health Organization, schizophrenia affects approximately 23 million people worldwide, or roughly 1 in 345 people.

While the identification of these 766 genes provides a comprehensive map, the next phase of research will likely focus on how these specific genes interact to trigger the onset of the disorder. Scientists will now work to determine which of these newly identified genes are the most influential drivers of the disease, potentially leading to new biomarkers for early diagnosis.